Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Report Date: November 9, 2023
Reporting Period: Fiscal Third Quarter ended September 30, 2023
This filing serves as a notification that the Company announced its financial results for the third quarter of 2023 via a press release. The detailed financial data is contained within the press release attached as Exhibit 99.1, which is incorporated by reference but explicitly stated as "furnished" rather than "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), but the text of the 8-K itself does not disclose them.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance compared to the prior comparable period. It only confirms the announcement of the third-quarter results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the results but does not include the text of management's commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing. The document notes that the information in the press release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 9, 2023) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics not included in this summary.
- Check for any forward-looking statements or guidance updates contained within the referenced press release.
- Confirm the status of the "furnished" versus "filed" designation for the press release content regarding liability under Section 18 of the Exchange Act.